Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
Cardiovascular Diseases (CVs) are one of the main causes of mortality and disability around the world. Advances in drug treatment have greatly improved survival and quality of life in the past decades, but associated adverse events remain a relevant problem. Pharmacogenetics can help individualize c...
Saved in:
Main Authors: | Xandra García-González, Sara Salvador-Martín |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/ee9c57be612740ca8986a2041b14ae6c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetics
Published: (1991) - Cardiology research and practice
-
Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
by: L. K. Khokhlov, et al.
Published: (2019) -
International journal of cardiology
Published: (1981) -
Pharmacogenetics of hypoglycemic agents
by: Irina Vladimirovna Kononenko, et al.
Published: (2015)